Bausch Health
303 hedge funds and large institutions have $4.29B invested in Bausch Health in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 121 increasing their positions, 84 reducing their positions, and 55 closing their positions.
44% more repeat investments, than reductions
Existing positions increased: 121 | Existing positions reduced: 84
19% more call options, than puts
Call options by funds: $146M | Put options by funds: $122M
12% more capital invested
Capital invested by funds: $3.83B → $4.29B (+$459M)
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
3% less funds holding
Funds holding: 312 → 303 (-9)
3.79% less ownership
Funds ownership: 69.78% → 65.99% (-3.8%)
13% less first-time investments, than exits
New positions opened: 48 | Existing positions closed: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$110M |
| 2 |
KKRC
Kohlberg Kravis Roberts & Co
New York
|
+$92.2M |
| 3 |
PC
Paulson & Co
New York
|
+$88.1M |
| 4 |
PIP
Permian Investment Partners
Dallas,
Texas
|
+$77.1M |
| 5 |
GCC
Guardian Capital (Canada)
Toronto,
Ontario, Canada
|
+$54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$267M |
| 2 |
Morgan Stanley
New York
|
-$95M |
| 3 |
Renaissance Technologies
New York
|
-$90.2M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$67.3M |
| 5 |
SPC
Slate Path Capital
New York
|
-$65.8M |
BHC Hedge Fund Activity: Q2 2020 in Review
303 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2020, worth a combined $4.29B — up 12% from $3.83B a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of BHC and 48 opened new positions — a net loss of 7 holders — while 84 trimmed existing stakes and 121 added.
The largest buyer was T. Rowe Price Associates, adding an estimated $110M. The largest seller was Fidelity International, cutting an estimated $267M.
- 303 institutional investors held Bausch Health (BHC) as of Q2 2020, down from 312 in Q1 2020.
- Funds reported $4.29B of Bausch Health stock for Q2 2020, up 12% quarter-over-quarter.
- 48 funds opened new Bausch Health positions in Q2 2020 and 55 closed out, a net change of -7 holders.
- The largest Bausch Health buyer in Q2 2020 was T. Rowe Price Associates, an estimated $110M added.
- The largest Bausch Health seller in Q2 2020 was Fidelity International, an estimated $267M sold.
Based on aggregated 13F filings for Q2 2020.